All Relations between Depression and serotonin

Publication Sentence Publish Date Extraction Date Species
Dawood Hossaini, Adam Khan Alipour, Meysam Sajjadi, Mustafa Ansari, Murtaza Haidar. Biotin Mitigates Alcohol Withdrawal-Induced Anxiety and Depression by Regulating Serotonin Metabolism, BDNF, Inflammation, and Oxidative Stress in Rats. Neuropsychopharmacology reports. vol 45. issue 1. 2025-01-04. PMID:39754400. biotin mitigates alcohol withdrawal-induced anxiety and depression by regulating serotonin metabolism, bdnf, inflammation, and oxidative stress in rats. 2025-01-04 2025-01-08 rat
Xiao Wang, Qinge Zhan. Clinical Manifestations. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 20 Suppl 3. 2025-01-03. PMID:39750305. :background: this randomized, open-label study examined the therapeutic effects of computerized cognitive training (cct) combined with selective serotonin reuptake inhibitors (ssris) on cognitive impairment among patients with late-life depression (lld). 2025-01-03 2025-01-05 Not clear
Meng-Ran Song, Ming-Zhi Huang, Wei-Jie Tao, Zheng Yong, Rui-Bin S. Tandospirone prevents anesthetic-induced respiratory depression through 5-HT Scientific reports. vol 15. issue 1. 2025-01-03. PMID:39753642. tandospirone prevents anesthetic-induced respiratory depression through 5-ht respiratory depression is a side effect of anesthetics. 2025-01-03 2025-01-06 rat
Yiming Zhou, Lijuan Chen, Meijing Wang, Yang Yang, Bin Hu, Guolin Li, Fang We. Paroxetine promotes longevity via ser-7-dop-4-IIS axis in Caenorhabditis elegans. GeroScience. 2024-12-27. PMID:39729241. paroxetine, a selective serotonin reuptake inhibitor, is widely used in the clinical treatment of depression. 2024-12-27 2024-12-29 caenorhabditis_elegans
Jiaqi Dong, Mingyue Liu, Suning Li, Siqi Zhang, Pengbin Fu, Mengya Liu, Shasha Jin, Chunliang Fan, Mingzhu Fang, Liang Wu, Zhe L. Adverse reactions associated with SSRIs and PD-1/PD-L1 inhibitors: a disproportionality analysis of the FDA adverse event reporting system. Expert opinion on drug safety. 2024-12-23. PMID:39714905. selective serotonin reuptake inhibitors (ssris) are the primary choice for antidepressant therapy in cancer patients with depression. 2024-12-23 2024-12-25 Not clear
Yu-Bin Lee, Ye-Jin Cho, Jeon-Kyung Ki. The unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 182. 2024-12-13. PMID:39671722. the unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. 2024-12-13 2024-12-21 Not clear
Yu-Bin Lee, Ye-Jin Cho, Jeon-Kyung Ki. The unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 182. 2024-12-13. PMID:39671722. we investigated changes in the gut microbiome regulated by fluoxetine and vagus nerve-mediated expression of several serotonin (5-ht) receptor types associated with anxiety and depression. 2024-12-13 2024-12-21 Not clear
Arzoo Pannu, Ramesh K Goya. The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future Aspects. CNS & neurological disorders drug targets. 2024-12-06. PMID:39639477. while the roles of serotonin and norepinephrine in depression have been extensively studied, the importance of dopaminergic pathways-essential for mood, cognition, motor control, and endocrine function-often gets overlooked. 2024-12-06 2024-12-08 Not clear
Amir Elalouf, Amit Yaniv Rosenfeld, Hanan Mao. Targeting serotonin receptors with phytochemicals - an in-silico study. Scientific reports. vol 14. issue 1. 2024-12-05. PMID:39638796. further in vitro and in vivo studies are warranted to explore their efficacy in alleviating stress and depression through their interactions with 5-ht receptors. 2024-12-05 2024-12-08 Not clear
Emma S Høgsted, Vincent Beliveau, Brice Ozenne, Martin K Madsen, Claus Svarer, Vibeke H Dam, Annette Johansen, Patrick Fisher, Gitte M Knudsen, Vibe G Frokjaer, Anjali Sanka. Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression. The British journal of psychiatry : the journal of mental science. 2024-12-05. PMID:39632615. consistent evidence that brain serotonin 2a receptor binding is positively associated with personality-based risk markers of depression. 2024-12-05 2024-12-07 Not clear
Sabrina Nguyen, Denzil Robinson, Alexander T Phan, Haroon Azhand, Dan V. Mirtazapine-Induced Premature Ventricular and Atrial Contractions. Journal of medical cases. vol 15. issue 12. 2024-11-29. PMID:39610911. mirtazapine, an alpha-2 adrenergic receptor, 5-hydroxytryptamine (5-ht)2, and 5-ht3 antagonist, is commonly used in patients for depression and anorexia. 2024-11-29 2024-12-01 Not clear
Erin A Clark, Lien Wang, Taleen Hanania, Karla Kretschmannova, Massimiliano Bianchi, Elizabeth Jagger, Tingting Hu, Fugang Li, Yasir Gallero-Salas, Kenneth S Koblan, Nina Dedic, Linda J Bristo. 5-HT Pharmacology, biochemistry, and behavior. 2024-11-28. PMID:39608648. 5-ht ketamine is noted for its rapid onset antidepressant response and effectiveness in patients with treatment resistant depression. 2024-11-28 2024-12-01 Not clear
L Batey, B Baumberger, H Khoshbouei, P Hashem. Lipopolysaccharide Effects on Neurotransmission: Understanding Implications for Depression. ACS chemical neuroscience. 2024-11-27. PMID:39601433. the levels of the monoamines dopamine, serotonin and norepinephrine are thought to be affected by both inflammation and depression. 2024-11-27 2024-11-29 Not clear
Xiao Wang, Jiaojiao Zhou, Kemeng Zhu, Yida Wang, Xianglin Ma, Li Ren, Chengwei Guo, Zhanjun Zhang, Peng Lu, Qinge Zhan. Efficacy and safety of Neurocognitive Adaptive Training for Depression combined with SSRIs for treating cognitive impairment among patients with late-life depression: a 12-week, randomized controlled study. BMC psychiatry. vol 24. issue 1. 2024-11-26. PMID:39587504. this randomized, open-label study examined the therapeutic effects of neurocognitive adaptive training for depression (ncat-d) combined with selective serotonin reuptake inhibitors (ssris) on cognitive impairment among patients with late-life depression (lld). 2024-11-26 2024-11-28 Not clear
Cong-Wei Zheng, Yu-Chieh Huang, Yuan-Liang Wen, Hui-Wen Yang, Sheng-Yin To, Li-Ting Ka. Suicide-related risk among patients using branded and generic fluoxetine: a propensity score-matched, new-user design in Taiwan. BMC psychiatry. vol 24. issue 1. 2024-11-23. PMID:39578788. depression is recognized to exacerbate suicide risk globally and selective serotonin reuptake inhibitors, such as fluoxetine are common treatment options. 2024-11-23 2024-11-25 Not clear
b' \\xc4\\xb0pek G\\xc3\\xbcldiken, Beg\\xc3\\xbcm Elbir, Andrei Nalimov, \\xc3\\x87a\\xc4\\x9fr\\xc4\\xb1 Delilba\\xc5\\x9f\\xc4\\xb. INVESTIGATION OF THE EFFECT OF THE ONSET OF BRUXISM AS A RESULT OF EARLY ANTIDEPRESSANT USE Psychiatria Danubina. vol Psychiatr Danub. issue 2. 2024-11-16. PMID:39546651.' investigation of the effect of the onset of bruxism as a result of early antidepressant use among antidepressants, selective serotonin and noradrenaline reuptake inhibitors (ssris and snris) have been widely used in the treatment of major depression and may induce sleep disorders and bruxism. 2024-11-16 2024-11-18 Not clear
Miyuan Zhang, Yuefeng Yang, Zhishuai Yang, Xin Wen, Cong Zhang, Peng Xiao, Yibo Wang, Jinpeng Sun, Hongshuang Wang, Xiaohui Wan. Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT European journal of medicinal chemistry. vol 281. 2024-11-14. PMID:39541872. structural insights into tryptamine psychedelics: the role of hydroxyl indole ring site in 5-ht recent advancements in the study of mushroom-derived tryptamines, particularly psilocybin and its metabolite psilocin, highlight their unique psychedelic properties and potential therapeutic applications, especially for mental health conditions like depression. 2024-11-14 2024-11-17 Not clear
Jiyang Li, Xinxing Fei, Shiqi Wang, Zhangyu Xu, Fangyuan Xu, Jianxiong Wang, Yaqian Gao, Yue H. A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants. Drug design, development and therapy. vol 18. 2024-11-11. PMID:39525047. many studies have been conducted on the use of selective serotonin reuptake inhibitors (ssris) for the treatment of depression. 2024-11-11 2024-11-17 Not clear
Takayoshi Tsubaki, Erina Kodaka, Yuhei Kitano, Maiko Kodama, Shintaro Fukumoto, Chihaya Takano, Shiro Iino, Yasuo Hiron. Effective Pain Management of Postherpetic Neuralgia Using a Combination of Analgesics and Conservative Measures. Cureus. vol 16. issue 11. 2024-11-07. PMID:39507605. due to the patient's depression and the concurrent use of a selective serotonin reuptake inhibitor, duloxetine hydrochloride could not be prescribed. 2024-11-07 2024-11-09 Not clear
Saeed Mahdianipur, Mahafarin Maralani, Saeed Mohammadi, Seyed Reza Khandoozi, Afifeh Jaefari, Homa Davood. Serotonin Availability Shapes the Effects of Phenelzine on Inflammatory Response and Gene Expression in Macrophages. Cureus. vol 16. issue 10. 2024-11-06. PMID:39502968. given the emerging evidence of a bidirectional link between depression and inflammation, as well as the potential therapeutic applications of serotonin-modulating drugs in autoimmune diseases and cancer, our study investigated the pro-inflammatory and anti-inflammatory factors influenced by serotonin and phenelzine. 2024-11-06 2024-11-08 Not clear